What we do

We develop and commercialize products for the diagnosis and treatment of sleep apnea and related health conditions. Our first product, BresoDX®, is an innovative device using proprietary acoustic and accelerometer technology to diagnose sleep apnea. BresoDX®, was developed at Toronto Rehabilitation Institute of the University Health Network (UHN) by Dr. Geoff Fernie, Dr. Douglas Bradley, and Dr. Hisham Alshaer.

Recent news

Financial Post: At-home sleep apnea test coming to Ontario this year, with costs covered

  Special to Financial Post, May 16, 2017 BresoDX is first device to come out of MaRS’ Excellence in Clinical Innovation Technology Evaluation program For the first time, Ontarians will be able to use an at-home device to test themselves for sleep apnea, a development facilitated by the innovative MaRS ...
Read more

The Ministry of Health and Long Term Care of Ontario launches a home sleep test demonstration project with BresoDX®

  Toronto, Canada, May 16, 2017 BresoDX®, developed by BresoTEC, has been selected by the Ministry of Health and Long-Term Care (MOHLTC) for use in a home-based sleep apnea demonstration project with sleep clinics across Ontario. For the first time in the province, patients and sleep physicians will have the ...
Read more

Central sleep apnea
Consequences and comorbidities of obstructive sleep apnea

Study showed that BresoDX® can distinguish patients with central from obstructive sleep apnea using overnight breath sound recordings Milan, Italy, September 12, 2017 A study showed that a BresoDX® sleep study was able to distinguish patients with central from obstructive sleep apnea. Data from the study were presented in an ...
Read more